Memory decline in healthy older people

Background: Criteria for mild cognitive impairment require objective evidence of a memory deficit but do not require objective evidence of memory decline. Application of these criteria may therefore result in the misclassification of older patients with memory decline as normal because their neuropsychological test performance at a single point in time may be within normal limits. This study aimed to identify and characterize older people with memory decline. Method: Word list delayed recall (WLDR) test performance was assessed on five occasions during a 2-year period in a cohort of healthy older individuals. Older people with declining (n = 35) and nondeclining (n = 66) WLDR scores were identified. Both subgroups were then compared on apoE genotype, Clinical Dementia Rating, and neuropsychological test performance at the fifth assessment. Results: Thirty-four percent of the group with declining memory recorded a Clinical Dementia Rating of 0.5, compared with 5% of the nondeclining memory group. No between-group differences were observed in cognitive domains other than memory, self-reported cognitive failures, or the proportion of each group carrying the apoE epsilon 4 allele. Conclusions: A large proportion of healthy older individuals show memory decline, which may represent the early stages of a potentially more severe cognitive impairment. Further investigation is necessary to determine the relationship between apoE genotype, self-reported cognitive impairment, and memory decline in older people.

[1]  D. Carmelli,et al.  Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .

[2]  E G Tangalos,et al.  Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects , 1998, Neurology.

[3]  H. Soininen,et al.  Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age‐associated memory impairment , 1994, Neurology.

[4]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[5]  J. Duchek,et al.  Mild senile dementia of the alzheimer type: 2. Longitudinal assessment , 1988, Annals of neurology.

[6]  F D Wolinsky,et al.  Identifying meaningful intra-individual change standards for health-related quality of life measures. , 2000, Journal of evaluation in clinical practice.

[7]  E. Tangalos,et al.  Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. , 1991, Psychology and aging.

[8]  R. Shafiq-Antonacci,et al.  The effects of age and mood on saccadic function in older individuals. , 1999, The journals of gerontology. Series B, Psychological sciences and social sciences.

[9]  C. Masters,et al.  Collection and normal levels of the amyloid precursor protein in plasma , 1997, Annals of neurology.

[10]  N Butters,et al.  Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.

[11]  M. Sliwinski,et al.  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1994, Neurology.

[12]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[13]  P. Maruff,et al.  The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment , 2000, Neuroscience & Biobehavioral Reviews.

[14]  S. Corkin,et al.  Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease , 1996, Neurology.

[15]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[16]  L. Bouter,et al.  Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. , 1999, The American journal of psychiatry.

[17]  M. Laakso,et al.  A Follow‐Up Study of Age‐Associated Memory Impairment: Neuropsychological Predictors of Dementia , 1995, Journal of the American Geriatrics Society.

[18]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[19]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[20]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[21]  L. Radloff.  The CES-D Scale , 1977 .

[22]  D. Broadbent,et al.  The Cognitive Failures Questionnaire (CFQ) and its correlates. , 1982, The British journal of clinical psychology.

[23]  K Yaffe,et al.  Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. , 1999, Archives of general psychiatry.

[24]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.

[25]  J. Semple,et al.  Computerized neuropsychological tests in the early detection of dementia: Prospective findings , 1997, Journal of the International Neuropsychological Society.

[26]  K. Marder,et al.  Neuropsychological detection and characterization of preclinical Alzheimer's disease , 1995, Neurology.

[27]  Walter Kukull,et al.  Progression to dementia in patients with isolated memory loss , 1997, The Lancet.

[28]  T. Erkinjuntti,et al.  Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals. , 2000, Archives of gerontology and geriatrics.

[29]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[30]  A. Mackinnon,et al.  Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample , 1997, Psychological Medicine.

[31]  B. Yankner.  Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[32]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[33]  C. Spielberger,et al.  STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire") , 1970 .

[34]  B. Winblad,et al.  Memory Complaints of Elderly People in a Population Survey: Variation According to Dementia Stage and Depression , 1993, Journal of the American Geriatrics Society.

[35]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[36]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[37]  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1995 .

[38]  R. Shafiq-Antonacci,et al.  Norms and the Effects of Demographic Variables on a Neuropsychological Battery for Use in Healthy Ageing Australian Populations , 1999, The Australian and New Zealand journal of psychiatry.

[39]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[40]  C. Clark,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Neurology.

[41]  J. Semple,et al.  Computerized delayed matching to sample and paired associate performance in the early detection of dementia. , 1995, Applied neuropsychology.

[42]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[43]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[44]  A. M. Owen,et al.  Visuospatial memory deficits at different stages of Parkinson's disease , 1993, Neuropsychologia.

[45]  N Butters,et al.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. , 1992, Archives of neurology.

[46]  A. Korten,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[47]  Adrian M. Owen,et al.  Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man , 1995, Neuropsychologia.

[48]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.